TAKE Solutions Limited Bombay S.E.

TAKE

INE142I01023

Biotechnology & Medical Research

Delayed Bombay S.E. Other stock markets 11:00:53 16/07/2024 BST			5-day change	1st Jan Change
20.43 ^INR	-1.26%		-1.11%	-11.41%

05-30	TAKE Solutions Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI
04-01	TAKE Solutions Limited Announces Resignation of P. Srinivasan as Company Secretary & Compliance Officer	CI

TAKE Solutions Limited Incorporates NAVITAS LIFESCIENCES S.A.S

January 04, 2018 at 12:11 pm

TAKE Solutions Limited has incorporated a step down subsidiary company “NAVITAS LIFESCIENCES S.A.S” in Colombia, on Jan. 3, 2018.

Latest news about TAKE Solutions Limited

TAKE Solutions Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	05-30	CI
TAKE Solutions Limited Announces Resignation of P. Srinivasan as Company Secretary & Compliance Officer	04-01	CI
TAKE Solutions Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-13	CI
TAKE Solutions Limited Approves the Shifting of Registered Office	11-08	CI
TAKE Solutions Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-08	CI
TAKE Solutions Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	14/08/23	CI
TAKE Solutions Limited Auditor Raises 'Going Concern' Doubt	16/07/23	CI
TAKE Solutions Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	29/05/23	CI
TAKE Solutions Limited Reports Earnings Results for the Full Year Ended March 31, 2023	29/05/23	CI
Take Solutions Divests Thailand-Based Arm	04/04/23	MT
An unknown buyer acquired Navitas Life Sciences Company Limited from TAKE Solutions Limited for $0.19 million.	31/03/23	CI
TAKE Solutions Completes Dissolution of US-based Unit	13/03/23	MT
TAKE Solutions Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	14/02/23	CI
TAKE Solutions Limited Appoints Kiran Sharma as an Additional Director (Non-Executive Independent Category)	14/02/23	CI
Take Solutions Names New CFO	02/01/23	MT
TAKE Solutions Limited Appoints Mr. Venkatesan. V as Chief Financial Officer	30/12/22	CI
TAKE Consultancy Services Inc announced that it expects to receive funding from TAKE Solutions Limited	17/10/22	CI

TAKE Solutions Limited is an India-based company, which delivers domain-intensive services as a full-service contract research organization (CRO) supporting pharma, biotech and devices companies across the globe. The Company, in life sciences sector, offers clients a combination of full-service clinical research, generics development, data sciences, regulatory affairs, and pharmacovigilance/safety services. Its extent of services spans from clinical trials to regulatory submissions to post-marketing safety, all backed by insights derived through proprietary industry networks forums. Its digital healthcare services include medical decision making (artificial intelligence and machine learning), and cloud adoption & mobility. Its global roster of clients includes large and small biopharmaceutical and devices companies, United States federal agencies like Centers for Disease Control and Prevention (CDC) and the United States Department of Defense (DoD), as well as generics manufacturers.

Sector

Biotechnology & Medical Research

Calendar

07/08/2024 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
MODERNA, INC.	+25.83%	46.56B
LONZA GROUP AG	+45.38%	41.67B
IQVIA HOLDINGS INC.	+0.69%	41.16B
ALNYLAM PHARMACEUTICALS, INC.	+30.52%	32.4B
ICON PUBLIC LIMITED COMPANY	+22.30%	28.18B
CELLTRION, INC.	-6.35%	28.1B
UNITED THERAPEUTICS CORPORATION	+49.25%	14.52B
MEDPACE HOLDINGS, INC.	+49.18%	13.74B
BIO-TECHNE CORPORATION	+3.45%	12.17B